Alpha Teknova, Inc. (TKNO) NASDAQ

4.40

-0.29(-6.18%)

Updated at August 18 03:37PM

Currency In USD

Alpha Teknova, Inc.

Address

2290 Bert Drive

Hollister, CA 95023

United States of America

Phone

831 637 1100

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

173

First IPO Date

June 25, 2021

Key Executives

NameTitlePayYear Born
Mr. Stephen GunstreamPresident, Chief Executive Officer & Director932,3011980
Mr. Damon A. Terrill J.D.General Counsel, Chief Compliance Officer & Secretary570,8981971
Mr. Matthew C. LowellChief Financial Officer591,5001971
Ms. Jennifer HenrySenior Vice President of Marketing0N/A

Description

Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.